1Moriarity JT,Folsom AR,Iribarren C,et al.Serum uric acid and risk of coronary heart disease:Atherosclerosis Risk in Communities(ARIC) Study.Ann Epidemiol,2000,10:136-143.
2Breckenridge A.Hypertension and hyperuricaemia.Lancet,1966,1:15-18.
3Cannon PJ,Stason WB,demartini FE,et al.Hyperurcemia in primary and renal hypertension.N Engl J Med,1966,275:457-464
4Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.?Hypertension,2003,41:1183-1190.
5Hoieggen A,Alderman MH,Kjeldsen SE,et al.The impact of serum uric acid on cardiovascular outcomes in the LIFE study.Kidney Int,2004,65:1041-1049.
7Nakashima M,Uematsu T,Kosuge K,et al.Pilot study of the uricosuric effect of DuP-753,a new angiotensin Ⅱ receptor antagonist,in healthy subjects.Eur J Clin Pharmacol,1992,42:333-335.
8Sweet CS,Bradstreet DC,Berman RS,et al.Pharmacodynamic activity of intravenous E-3174,an angiotensin Ⅱ antagonist,in patients with essential hypertension.Am J Hypertens,1994,7:1035 -1040.
9Wurzner G,Gester JC,Chiolero A,et al.Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.J Hypertens,2001,19:1855-1860.
10Takahashi S,Moriwaki Y,Yamamoto T,et al.Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.Ann Rheum Dis,2003,62:572-575.
